Professional background
Dr Heather Shaw is a consultant medical oncologist and lead for the medical oncology skin cancer service at University College London Hospital. She also works at Mount Vernon Cancer Centre in Northwood, London. Dr Shaw's main interests include the development of new strategies for the treatment of melanoma, including rare subtypes such as ocular, and novel therapies to overcome resistance to currently available treatments and maximise benefit for patients. She has a specialty interest in the management of immunotherapy adverse events and is involved in development of local and national guidance while leading services in both institutions for acute patient management.
Dr Shaw is the oncology representative on the Skin Cancer Prevention Group of the British Association of Dermatologists, a member of the national Uveal Melanoma Surveillance Guideline Committee, The Advanced Cellular Therapy Sub-Committee of British Society of Bone Marrow Transplantation and Cellular Therapy and has provided governmental advisory input to the UK All Party Parliamentary Group on Cancer with regard to cutaneous squamous cell carcinoma.
She is currently national coordinating investigator for a several international groundbreaking melanoma studies including cellular and vaccine therapy indications which will deliver first in class licensed indications, and Principal Investigator for a large portfolio of melanoma, cutaneous squamous cell carcinoma, and early phase studies including first in human.